James Vardiman to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications James Vardiman has written about Antimetabolites, Antineoplastic.
Connection Strength
0.013
-
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461. Ann Hematol. 2004; 83 Suppl 1:S84-5.
Score: 0.013